Hepatitis C
📧 Sign up to get email alerts when something new happens for Hepatitis C.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2010-08-31Clinical Trial Update: Pegasys® Plus Ribavirin in Thalassemic Patients With Hepatitis C Virus Infection [Phase 4]
Phase 4 trial update evaluating Pegasys (pegylated interferon alfa-2a) plus ribavirin in patients with hepatitis C and thalassemia; the stud…
-
CLINICAL_TRIALS trial_result · 2010-08-27Clinical Trial Update: Interferon-Induced Gene Expression in Liver Cells and Peripheral Blood Lymphocytes [Phase 2]
A Phase 2 clinical trial evaluating interferon-induced gene expression in liver cells and peripheral blood lymphocytes in individuals with H…
-
CLINICAL_TRIALS trial_result · 2010-08-10Clinical Trial Update: Thymosin Alpha-1 in Combination With Peg-Interferon Alfa- 2a and Ribavirin for the Therapy of Chronic Hepatitis C Nonresponsive to the Combination of IFN and Ribavirin. [Phase 3]
Completed Phase 3 trial evaluating thymosin alpha-1 in combination with peg-interferon alfa-2a and ribavirin for chronic hepatitis C patient…
-
CLINICAL_TRIALS research · 2010-08-10Clinical Trial Update: Exploration of Chronic Hepatitis C Infection Receiving 24-week Interferon-α With Ribavirin Treatments
This clinical trial listing from National Taiwan University Hospital describes a 24-week interferon-α with ribavirin treatment for chronic h…
-
CLINICAL_TRIALS trial_result · 2010-07-16Clinical Trial Update: Effects of Pegylated Interferon Alfa-2b and Ribavirin After Orthotopic Liver Transplantation in Subjects With Chronic Hepatitis C Recurrence (P04590AM3)(COMPLETED) [Phase 3]
A completed Phase 3 trial evaluating pegylated interferon alfa-2b with ribavirin in liver transplant recipients with chronic Hepatitis C rec…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2010-07-16Clinical Trial Update: A Phase 1b, Single Center, Clinical Study to Investigate the Safety and Biological Responses to Baminercept in Patients With Chronic HCV Hepatitis. [Phase 1]
Phase 1b, single-center trial evaluating the safety and biological responses to Baminercept in patients with chronic hepatitis C, with unkno…
-
CLINICAL_TRIALS trial_result · 2010-07-09Clinical Trial Update: Do Low High Density Lipoprotein (HDL) Levels Predict Treatment Outcome in Patients With Chronic Hepatitis C Viral Infection?
A completed clinical trial investigated whether low HDL cholesterol levels predict treatment outcomes in chronic hepatitis C infection.
-
CLINICAL_TRIALS trial_result · 2010-07-05Clinical Trial Update: A Study of Induction Dosing With PEGASYS (Peginterferon Alfa-2a [40KD]) Plus Copegus in Treatment-Naive Patients With Chronic Hepatitis C [Phase 4]
Phase 4 trial update evaluating induction dosing with PEGASYS plus Copegus in treatment-naive chronic hepatitis C patients; results posted i…
-
CLINICAL_TRIALS trial_result · 2010-06-30Clinical Trial Update: Pegaferon and Ribavirin for Hepatitis C [Phase 3]
Phase 3 trial of Pegaferon plus Ribavirin for Hepatitis C has completed.
-
CLINICAL_TRIALS trial_result · 2010-06-24Clinical Trial Update: Treatment of Patients With Chronic Hepatitis C With PegIntron as Monotherapy or in Combination With Ribavirin (Study P04437)(COMPLETED)
This clinical trial update reports on PegIntron (pegylated interferon alfa-2b) as monotherapy or in combination with ribavirin for chronic h…
-
CLINICAL_TRIALS trial_result · 2010-06-15Clinical Trial Update: A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Plus COPEGUS (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Genotype 1 and Human Immunodeficiency Virus-1 (HIV-1) Co-infection [Phase 4]
Phase 4 trial update of peginterferon alfa-2a plus ribavirin in patients with chronic hepatitis C genotype 1 co-infected with HIV-1; the stu…
-
CLINICAL_TRIALS trial_result · 2010-06-10Clinical Trial Update: Valopicitabine Alone and Together With Pegylated Interferon in Patients With Chronic Hepatitis C Who Have Failed to Respond to Standard Therapy [Phase 2]
A Phase 2 clinical trial evaluated valopicitabine alone and in combination with pegylated interferon in patients with chronic hepatitis C wh…
-
CLINICAL_TRIALS trial_result · 2010-06-10Clinical Trial Update: Study to Evaluate Drug-drug Interaction Between Valopicitabine and Ribavirin [Phase 2]
A completed Phase 2 study evaluated potential drug-drug interactions between valopicitabine and ribavirin in patients with chronic hepatitis…
-
CLINICAL_TRIALS trial_result · 2010-06-10Clinical Trial Update: Valopicitabine When Administered Alone and in Combination With Interferon to Treatment-Naive Patients With Hepatitis C [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating valopicitabine alone and in combination with interferon in treatment-naive patients with chronic hepat…
-
CLINICAL_TRIALS trial_result · 2010-06-07Clinical Trial Update: Study of HCV Genotype 1 Patients in the UK Treated With ViraferonPeg and Rebetol (Study P05269)(COMPLETED)
A completed UK study (P05269) evaluated the combination of ViraferonPeg and Rebetol in hepatitis C genotype 1 patients, with results posted …
-
CLINICAL_TRIALS trial_result · 2010-06-03Clinical Trial Update: A Study of Peginterferon Alfa-2a in Combination With Ribavirin in Chronic Hepatitis C (CHC) Patients With Compensated Liver Cirrhosis (LC) [Phase 3]
Phase 3 trial update of peginterferon alfa-2a in combination with ribavirin for chronic hepatitis C patients with compensated liver cirrhosi…
-
CLINICAL_TRIALS trial_result · 2010-05-18Clinical Trial Update: Low Dose Peginterferon-α 2a for Chronic Hepatitis C, Genotypes 2 or 3, in HIV-coinfected Patients [Phase 4]
A Phase 4 trial evaluated low-dose peginterferon-α2a for chronic hepatitis C genotypes 2 or 3 in HIV-coinfected patients; the study status i…
-
CLINICAL_TRIALS trial_result · 2010-05-17Clinical Trial Update: TMC435-TiDP16-C121: A Study Comparing 2 Tablet Formulations of TMC435 to an Established Capsule Formulation and Evaluating the Effect of Food on Blood Levels of TMC435 [Phase 1]
A Phase 1 trial comparing two tablet formulations of TMC435 to an established capsule formulation and evaluating the effect of food on blood…
-
CLINICAL_TRIALS trial_result · 2010-05-17Clinical Trial Update: Post-marketing Surveillance Study of Ex-intravenous Drug Abusers With Chronic Hepatitis C Treated With PegIntron Plus Rebetol (P04408/MK-4031-261)
Post-marketing surveillance study of ex-intravenous drug abusers with chronic hepatitis C treated with PegIntron plus Rebetol; results were …
-
CLINICAL_TRIALS trial_result · 2010-05-17Clinical Trial Update: Adherence in Patients Receiving PegIntron Pen/Rebetol for Hepatitis C in Conjunction With a Patient Assistance Program (Study P04281)(COMPLETED)
This completed clinical trial update describes adherence to PegIntron (peginterferon alfa-2b) and Rebetol (ribavirin) in hepatitis C patient…
-
CLINICAL_TRIALS trial_result · 2010-05-07Clinical Trial Update: Injecting Drug Use Community Intervention Trial [Phase 3]
Phase 3 clinical trial evaluating a community intervention for people who inject drugs. The study targets HIV, Hepatitis C, syphilis, and HS…
-
CLINICAL_TRIALS trial_result · 2010-05-05Clinical Trial Update: Safety and Efficacy of the Therapeutic Vaccine GI-5005 Versus Placebo for the Treatment of Chronic Hepatitis C Infection [Phase 1]
Phase 1 clinical trial update reports safety and preliminary efficacy results of GI-5005 versus placebo for chronic hepatitis C infection. T…
-
CLINICAL_TRIALS trial_result · 2010-04-28Clinical Trial Update: TMC435350-TiDP16-C106: A Phase I Trial to Compare the Bioavailability and Plasma Pharmacokinetics After a Single Oral Dose of TMC435350 of 2 Different Solid Formulations Relative to a Powder Blend Capsule [Phase 1]
A Phase I study comparing the bioavailability and pharmacokinetics of two solid formulations of TMC435350 versus a powder blend capsule in H…
-
CLINICAL_TRIALS trial_result · 2010-04-28Clinical Trial Update: TMC435-TiDP16-C107: This Study Measures the (Possible) Influence of TMC435 on the Activity of a Selected Set of Drug-degrading Proteins by Measuring the Blood Levels of Drugs That Have Been Taken Together With TMC435 and That Are Known to be Specifically Degraded by These Drug-degrading Proteins. [Phase 1]
Phase 1 study to assess whether TMC435 influences the activity of drug-degrading proteins by measuring blood levels of coadministered drugs …
-
CLINICAL_TRIALS trial_result · 2010-04-28Clinical Trial Update: TMC435350-TiDP16-C109: A Safety Study for TMC435350 in an Oral Solution Containing Either 100, 200 or 400 mg Equivalent of TMC435350 or Placebo in Healthy Japanese Male Volunteers [Phase 1]
This Phase 1 safety study evaluated oral solutions of TMC435350 at 100, 200 or 400 mg (equivalent) versus placebo in healthy Japanese male v…